(Q42540911)

2 November 2017

title

Renal dysfunction and the treatment of inflammatory bowel disease (IBD): a case for monitoring (English)

1 reference

inflammatory bowel diseases

2 November 2017

main subject

1 reference

Howard G

1

1 reference

2 November 2017

Lynn KL

series ordinal

2

1 reference

2 November 2017

publication date

1 June 1998

1 reference

Australian and New Zealand journal of medicine

2 November 2017

published in

1 reference

2 November 2017

volume

28

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

346

1 reference

Current management of inflammatory bowel disease

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01962.X

Clinical perspectives in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01962.X

Tests of renal function in patients with quiescent colitis: effects of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01962.X

Mesalazine-associated interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01962.X

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01962.X

10.1111/J.1445-5994.1998.TB01962.X

21 January 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference